Impact of human papillomavirus vaccine on cervical cancer epidemic: Evidence from the surveillance, epidemiology, and end results program

INTRODUCTION: Since 2006, the human papillomavirus (HPV) vaccine has been recommended for females aged 9–26 years in the United States. Aiming to evaluate the early effect of the HPV vaccine on cervical cancer, this study assessed the incidence of cervical cancer by age and histology before and afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Jiao, Shu, Ting, Wu, Chenyao, Li, Mandi, Xu, Minghan, Jiang, Min, Zhu, Cairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859059/
https://www.ncbi.nlm.nih.gov/pubmed/36684904
http://dx.doi.org/10.3389/fpubh.2022.998174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859059/
https://www.ncbi.nlm.nih.gov/pubmed/36684904
http://dx.doi.org/10.3389/fpubh.2022.998174

Ejemplares similares